Skip to main content
Canna~Fangled Abstracts

Medicinal cannabis in neurodegenerative disorders: an open label, dose finding, safety and efficacy study

By April 19, 2024April 28th, 2024No Comments


doi: 10.2217/nmt-2023-0011.

Online ahead of print.
Affiliations 

Abstract

Aim: Currently, there exist no curative treatments for neurodegenerative disorders. Recently, there has been a resurgence of interest in the use of medicinal cannabis to improve neurological conditions.

Methods: A 12-month, open label, dose-finding, safety and efficacy study was conducted including 48 subjects with a variety of neurodegenerative disorders.

Results: In our participants, we observed a reduction in pain, improved sleep, enhanced well-being and less agitation.

Conclusion: Our findings suggest that medicinal cannabis might be useful in patients with neurodegenerative disorders in controlling pain, enhancing sleep, reducing difficult behaviors, controlling unusual and complex symptoms when other treatments have failed – this offers medicinal cannabis a role in palliation.

Keywords: medicinal cannabis, neurodegenerative disorders, open label, pain, sleep

PubMed Disclaimer

Leave a Reply